• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病淀粉样蛋白级联事件之间的时间。

Time between milestone events in the Alzheimer's disease amyloid cascade.

机构信息

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Sweden; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, United States.

Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, CA, United States.

出版信息

Neuroimage. 2021 Feb 15;227:117676. doi: 10.1016/j.neuroimage.2020.117676. Epub 2020 Dec 24.

DOI:10.1016/j.neuroimage.2020.117676
PMID:33359337
Abstract

OBJECTIVE

Estimate the time-course of the spread of key pathological markers and the onset of cognitive dysfunction in Alzheimer's disease.

METHODS

In a cohort of 335 older adults, ranging in cognitive functioning, we estimated the time of initial changes of Aβ, tau, and decreases in cognition with respect to the time of Aβ-positivity.

RESULTS

Small effect sizes of change in CSF Aβ42 and regional Aβ PET were estimated to occur several decades before Aβ-positivity. Increases in CSF tau occurred 7-8 years before Aβ-positivity. Temporoparietal tau PET showed increases 4-5 years before Aβ-positivity. Subtle cognitive dysfunction was observed 4-6 years before Aβ-positivity.

CONCLUSIONS

Increases in tau and cognitive dysfunction occur years before commonly used thresholds for Aβ-positivity. Explicit estimates of the time for these events provide a clearer picture of the time-course of the amyloid cascade and identify potential windows for specific treatments.

摘要

目的

估计阿尔茨海默病关键病理标志物扩散和认知功能障碍发作的时间进程。

方法

在认知功能不同的 335 名老年人队列中,我们根据 Aβ 阳性时间估计了 Aβ、tau 和认知下降的初始变化时间。

结果

脑脊液 Aβ42 和区域性 Aβ PET 变化的小效应量估计在 Aβ 阳性前几十年就发生了。脑脊液 tau 的增加发生在 Aβ 阳性前 7-8 年。颞顶叶 tau PET 显示在 Aβ 阳性前 4-5 年增加。在 Aβ 阳性前 4-6 年就观察到了轻微的认知功能障碍。

结论

tau 的增加和认知功能障碍发生在 Aβ 阳性常用阈值之前数年。这些事件时间的明确估计提供了淀粉样蛋白级联的时间进程更清晰的画面,并确定了特定治疗的潜在窗口期。

相似文献

1
Time between milestone events in the Alzheimer's disease amyloid cascade.阿尔茨海默病淀粉样蛋白级联事件之间的时间。
Neuroimage. 2021 Feb 15;227:117676. doi: 10.1016/j.neuroimage.2020.117676. Epub 2020 Dec 24.
2
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
3
Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.皮质微结构测量与阿尔茨海默病中的淀粉样蛋白病理学有关。
Brain. 2023 Apr 19;146(4):1602-1614. doi: 10.1093/brain/awac343.
4
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
5
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.在女性和淀粉样蛋白阳性的年轻受试者中,tau 聚集物的积累速度更高。
Brain. 2020 Dec 1;143(12):3805-3815. doi: 10.1093/brain/awaa327.
6
Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.临床诊断为阿尔茨海默病患者的脑淀粉样蛋白-β沉积与血液生物标志物。
J Alzheimers Dis. 2019;69(1):169-178. doi: 10.3233/JAD-190056.
7
The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.淀粉样蛋白-β或tau 在存在严重脑血管疾病的情况下对认知变化的影响。
J Alzheimers Dis. 2020;78(2):573-585. doi: 10.3233/JAD-200680.
8
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.小胶质细胞活化与阿尔茨海默病中的 tau 和淀粉样蛋白在体内相关。
Brain. 2018 Sep 1;141(9):2740-2754. doi: 10.1093/brain/awy188.
9
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.阿尔茨海默病的脑脊液生物标志物与淀粉样蛋白-β PET 一致,并可预测临床进展:在 BioFINDER 和 ADNI 队列中使用全自动免疫分析的研究。
Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi: 10.1016/j.jalz.2018.01.010. Epub 2018 Mar 1.
10
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease.脑脊液 GAP-43 升高与阿尔茨海默病中 tau 积累和扩散的加速有关。
Nat Commun. 2024 Jan 3;15(1):202. doi: 10.1038/s41467-023-44374-w.

引用本文的文献

1
Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation.使用位置、尺度和形状广义相加模型(GAMLSS)对不同人群中与年龄相关的淀粉样β动力学进行建模:横断面轨迹和纵向验证。
Alzheimers Dement. 2025 Sep;21(9):e70675. doi: 10.1002/alz.70675.
2
Factors associated with age at tau pathology onset and time from tau onset to dementia in Alzheimer's disease.与阿尔茨海默病中tau病理开始年龄以及从tau开始到痴呆的时间相关的因素。
Alzheimers Dement. 2025 Aug;21(8):e70551. doi: 10.1002/alz.70551.
3
Executive functioning and processing speed as predictors of global cognitive decline in Alzheimer's disease.
执行功能和处理速度作为阿尔茨海默病整体认知衰退的预测指标。
J Alzheimers Dis Rep. 2025 Aug 6;9:25424823251363549. doi: 10.1177/25424823251363549. eCollection 2025 Jan-Dec.
4
Age of menopause and dementia risk in 10,832 women from the Swedish Twin Registry.来自瑞典双胞胎登记处的10832名女性的绝经年龄与痴呆风险
Alzheimers Dement. 2025 Aug;21(8):e70541. doi: 10.1002/alz.70541.
5
Differential Impacts of Road Diets on Driving Behavior among Older Adults with and without Preclinical Alzheimer's Pathology.道路缩减措施对有和没有临床前阿尔茨海默病病理特征的老年人驾驶行为的不同影响。
Transp Res Part F Traffic Psychol Behav. 2023 Oct;98:18-28. doi: 10.1016/j.trf.2023.08.010. Epub 2023 Aug 26.
6
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations.与神经正常人群相比,正电子发射断层扫描(PET)测量显示,唐氏综合征患者大脑中β淀粉样蛋白的积累速度加快。
Alzheimers Dement. 2025 Jun;21(6):e70357. doi: 10.1002/alz.70357.
7
Factors associated with age at tau pathology onset and time from tau onset to dementia.与tau病理开始年龄以及从tau开始到痴呆的时间相关的因素。
medRxiv. 2025 Mar 13:2025.03.11.25323773. doi: 10.1101/2025.03.11.25323773.
8
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.阿尔茨海默病淀粉样蛋白PET和脑脊液生物标志物临床应用的考量
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.
9
Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting.血清生物标志物作为临床环境中阿尔茨海默病的预后标志物。
Alzheimers Dement (Amst). 2025 Jan 29;17(1):e70071. doi: 10.1002/dad2.70071. eCollection 2025 Jan-Mar.
10
APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory Decline.APOE4增加对淀粉样蛋白的易感性,加速情景记忆衰退。
bioRxiv. 2024 Dec 24:2024.12.23.630203. doi: 10.1101/2024.12.23.630203.